5 years ago

Multivalent Peptide–Nanoparticle Conjugates for Influenza-Virus Inhibition

Multivalent Peptide–Nanoparticle Conjugates for Influenza-Virus Inhibition
Daniel Lauster, Christian P. R. Hackenberger, Ute Hoffmann, Maria Glanz, Rainer Haag, Andreas Herrmann, Christoph Böttcher, Markus Bardua, Markus Hellmund, Kai Ludwig, Alf Hamann
To inhibit binding of the influenza A virus to the host cell glycocalyx, we generate multivalent peptide–polymer nanoparticles binding with nanomolar affinity to the virus via its spike protein hemagglutinin. The chosen dendritic polyglycerol scaffolds are highly biocompatible and well suited for a multivalent presentation. We could demonstrate in vitro that by increasing the size of the polymer scaffold and adjusting the peptide density, viral infection is drastically reduced. Such a peptide–polymer conjugate qualified also in an in vivo infection scenario. With this study we introduce the first non-carbohydrate-based, covalently linked, multivalent virus inhibitor in the nano- to picomolar range by ensuring low peptide-ligand density on a larger dendritic scaffold. Peptides against viruses: Multivalent peptide–polymer nanoparticles are used as cellular-entry blockers for the influenza A virus. Different polymer sizes and ligand densities are compared for an effective cellular infection. It could be shown that the peptide–polymer conjugates are effective in in vitro and also in in vivo studies.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1002/anie.201702005

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.